585 related articles for article (PubMed ID: 17982119)
21. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
Moinfar F; Okcu M; Tsybrovskyy O; Regitnig P; Lax SF; Weybora W; Ratschek M; Tavassoli FA; Denk H
Cancer; 2003 Aug; 98(4):703-11. PubMed ID: 12910513
[TBL] [Abstract][Full Text] [Related]
22. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathologic features and treatment of ductal carcinoma in situ of the breast].
Zhou L; Wang Y; Song X; Du JW; Pei F; Huang LP; Wang WY; Liu ZB; Pan RQ
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3035-8. PubMed ID: 16324401
[TBL] [Abstract][Full Text] [Related]
24. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
[TBL] [Abstract][Full Text] [Related]
25. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
26. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.
Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A
Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
29. Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial.
Decensi A; Puntoni M; Pruneri G; Guerrieri-Gonzaga A; Lazzeroni M; Serrano D; Macis D; Johansson H; Pala O; Luini A; Veronesi P; Galimberti V; Dotti MC; Viale G; Bonanni B
Cancer Prev Res (Phila); 2011 Aug; 4(8):1181-9. PubMed ID: 21685235
[TBL] [Abstract][Full Text] [Related]
30. Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situ.
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Shiraiwa M; Nishida C; Morita T; Sato Y; Hayashi T; Kato A; Aoyama H; Yoshikawa K
Histopathology; 2011 May; 58(6):835-46. PubMed ID: 21401704
[TBL] [Abstract][Full Text] [Related]
31. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptors in canine mammary tumors.
MacEwen EG; Patnaik AK; Harvey HJ; Panko WB
Cancer Res; 1982 Jun; 42(6):2255-9. PubMed ID: 7074608
[TBL] [Abstract][Full Text] [Related]
33. Hyperplastic and neoplastic lesions of the mammary gland in macaques.
Wood CE; Usborne AL; Starost MF; Tarara RP; Hill LR; Wilkinson LM; Geisinger KR; Feiste EA; Cline JM
Vet Pathol; 2006 Jul; 43(4):471-83. PubMed ID: 16846989
[TBL] [Abstract][Full Text] [Related]
34. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
Ferreira E; Gobbi H; Saraiva BS; Cassali GD
Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
[TBL] [Abstract][Full Text] [Related]
35. Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases.
Ressel L; Millanta F; Poli A
J Comp Pathol; 2011 May; 144(4):303-7. PubMed ID: 20961557
[TBL] [Abstract][Full Text] [Related]
36. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
[TBL] [Abstract][Full Text] [Related]
37. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
[TBL] [Abstract][Full Text] [Related]
39. Some DCIS is different molecularly from DCIS with co-existing IDC.
Steinman S; Bourne P; Yang Q; Tang P; Wang J
Breast J; 2008; 14(1):122-3. PubMed ID: 18186882
[No Abstract] [Full Text] [Related]
40. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
